CDC in Central Asia by Center for Global Health (U.S.)
The Centers for Disease Control and Prevention (CDC) 
established a Central Asia regional office at the U.S. consulate 
in Kazakhstan in 1995. In 2005, CDC expanded its operations 
to focus on HIV and tuberculosis, through support from 
the U.S. President’s Emergency Plan for AIDS Relief. CDC 
continues to work with the region’s ministries of public 
health to address HIV, tuberculosis, and influenza, as well 
as on strengthening laboratory, surveillance, and workforce 
capacity to respond to disease outbreaks.
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HIV and Tuberculosis
HIV is a leading cause of death and a health threat to millions worldwide. As a key 
implementer of the U.S. President’s Emergency Plan for AIDS Relief (PEPFAR), CDC 
works with the governments of the Central Asia region (primarily Kazakhstan, 
Kyrgyzstan, and Tajikistan) to build sustainable, high-impact national HIV response 
programs with the goal of achieving epidemic control of HIV. CDC supports the use 
of epidemiological data to develop and scale up high-impact HIV prevention and 
treatment services that reach key populations (particularly persons who inject drugs) 
in high-burden regions. CDC also provides direct financial and technical assistance to 
Republican AIDS Centers and Republican Narcological Centers in all three countries, 
which supports these government organizations to develop and execute evidence-
based strategies and guidelines for HIV infection control.
Global Health Security
Helping countries respond to public health threats quickly and effectively within their 
borders is critical to prevent the spread of disease regionally and around the world. 
CDC works in the Central Asia region with local, regional, and global public health 
organizations to support disease outbreak response, surveillance, laboratory systems, 
and workforce development. The Global Health Security Agenda (GHSA) is a global 
partnership launched in 2014 to help make the world safer and more secure from 
infectious disease threats. Kazakhstan is a GHSA partner country, and CDC and the 
Kazakhstan Ministry of Health (MOH) are working together to carry out joint global 
health security activities.  In Uzbekistan, with CDC support, the MOH established 
a National Center for Antimicrobial Resistance (AMR), which is responsible for 
conducting AMR surveillance, antimicrobial susceptibility testing, and reporting data. 
CDC also works with the Uzbekistan MOH on Hepatitis C elimination. 
Cooperative Biological Engagement Program
Through collaboration with the Defense Threat Reduction Agency and the 
Cooperative Biological Engagement Program, CDC builds clinical and laboratory 
capacity in the region to minimize biosecurity threats. In Kazakhstan, CDC staff, in 
collaboration with the MOH, strengthen public health workforce capacity by training 
clinicians and laboratory specialists to recognize and confirm cases of especially 
dangerous pathogens (EDPs). CDC is working with public health laboratories across 
Kazakhstan to build a robust network of laboratories by strengthening quality 
management systems, standard operating procedures, training requirements, and the 
legal and regulatory framework governing laboratories in the country. CDC also works 
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Developed an electronic HIV case 
management system used by all AIDS 
Centers, primarily in Kazakhstan, 
Kyrgyzstan, and Tajikistan, to provide 
reliable real-time data on HIV epidemics.
As of 2019, 14 FETP cohorts have been 
recruited with more than 105 completed 
training and 23 currently in training in 
the region. Since its inception in 2003, 
the program’s residents have conducted 
more than 220 outbreak investigations 
and surveillance program evaluations. 
About 85% of FETP graduates work in their 
respective government’s health systems.
With technical support from CDC, 
Kazakhstan is participating in international 
influenza virus monitoring and contributes 
local strains to international influenza virus 
banks.
Supported the government of Uzbekistan 
in establishing a National Center for AMR. 
The center, launched in 2017, is responsible 
for all AMR-related activities in the country, 
including performing antimicrobial 
susceptibility testing, implementing AMR 
surveillance, and disseminating AMR data.
In 2019, Kazakhstan opened an Emergency 
Operations Center within the MOH with 
the assistance of CDC. The EOC Director 
was trained under CDC’s Public Health 
Emergency Management fellowship in 
Atlanta.
KAZAKHSTAN KYRGYZSTAN TAJIKISTAN UZBEKISTAN
  Population 18,037,646 (2017) 6,201,500 (2017) 8,921,343 (2017) 32,387,200 (2017)
  Per Capita Income $23,440 $3,620 $3,670 $7,130
  Life Expectancy  at Birth F 77/M 68 years F 75/M 67 years F 74/M 68 years F 76/M 71 years
  Infant Mortality Rate 9/1,000 live births 17/1,000 live births 27/1,000 live births 11/1,000 live births
  Top 10 Causes of 
  Death
1. lschemic heart disease
2. Stroke
3. Cirrhosis
4. Cardiomyopathy
5. Chronic obstructive pulmonary disease
6. Alzheimer’s disease
7. Self-harm
8. Lower respiratory infections
9. Lung cancer
10. Road injuries
1. lschemic heart disease
2. Stroke
3. Cirrhosis
4. Neonatal disorders
5. Chronic obstructive pulmonary disease
6. Road injuries
7. Lower respiratory infections
8. Alzheimer’s disease 
9. Stomach cancer
10. Self-harm
1. lschemic heart disease
2. Lower respiratory infections
3. Stroke
4. Neonatal disorders
5. Diarrheal diseases
6. Cirrhosis
7. Hypertensive heart disease
8. Diabetes
9. Congenital defects
10. Alzheimer’s disease
1. lschemic heart disease
2. Stroke
3. Cirrhosis
4. Lower respiratory infections
5. Diabetes
6. Neonatal disorders
7. Alzheimer’s disease
8. Road injuries 
9. Chronic kidney disease
10. Hypertensive heart disease
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in Kazakhstan with the MOH, hospitals and public health laboratories to improve 
the surveillance and testing of EDPs and antimicrobial drug-resistant pathogens. In 
Uzbekistan, CDC assists the MOH to develop scientific and practical guidelines for 
EDPs (most recently brucellosis and Crimean-Congo hemorrhagic fever) and designs 
and conducts seminars focused on developing policies, tools and best practices for 
EDPs.   
Field Epidemiology Training Program 
CDC supports Kazakhstan and Kyrgyzstan in strengthening the capacity of 
their workforce to investigate and respond to disease outbreaks through the 
Field Epidemiology Training Program (FETP). FETP trains a workforce of field 
epidemiologists—or disease detectives—to identify and contain outbreaks before 
they become epidemics. Participants focus on “learning by doing” to develop the 
skills for gathering critical data and turning it into evidence-based action. The Central 
Asia FETP was established in 2003 in partnership with the MOHs in the Central Asian 
region. Over the years, Tajikistan and Uzbekistan have ceased active participation. 
Kazakhstan is currently transitioning the program to the local government with CDC 
guidance. 
Influenza
Influenza viruses are constantly changing and require continued vigilance to protect 
the United States and the rest of the world from seasonal influenza and novel viruses 
that could trigger a pandemic. CDC works with the Kyrgyzstan MOH to help build 
surveillance and laboratory capacity to prevent, detect, and respond to influenza 
threats. In Kyrgyzstan, CDC helped establish National Influenza Centers, which are part 
of the Global Influenza Surveillance and Response System. In Kazakhstan, CDC worked 
with the MOH to establish nine sentinel surveillance sites, whose data is reported by 
the national government to the World Health Organization (WHO). Kazakhstan no 
longer receives direct assistance from CDC, but maintains an active partnership with 
CDC and WHO and follows International Health Regulation standards and practices. 
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